11-1244556-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_002458.3(MUC5B):​c.7676C>T​(p.Thr2559Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.385 in 1,601,592 control chromosomes in the GnomAD database, including 69,187 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T2559A) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.42 ( 12953 hom., cov: 25)
Exomes 𝑓: 0.38 ( 56234 hom. )

Consequence

MUC5B
NM_002458.3 missense

Scores

1
15

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -3.90

Publications

13 publications found
Variant links:
Genes affected
MUC5B (HGNC:7516): (mucin 5B, oligomeric mucus/gel-forming) This gene encodes a member of the mucin family of proteins, which are highly glycosylated macromolecular components of mucus secretions. This family member is the major gel-forming mucin in mucus. It is a major contributor to the lubricating and viscoelastic properties of whole saliva, normal lung mucus and cervical mucus. This gene has been found to be up-regulated in some human diseases, including sinus mucosa of chronic rhinosinusitis (CRS), CRS with nasal polyposis, chronic obstructive pulmonary disease (COPD) and H. pylori-associated gastric disease, and it may be involved in the pathogenesis of these diseases. [provided by RefSeq, Jul 2010]
MUC5B-AS1 (HGNC:53936): (MUC5B antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=2.851046E-5).
BP6
Variant 11-1244556-C-T is Benign according to our data. Variant chr11-1244556-C-T is described in ClinVar as Benign. ClinVar VariationId is 403143.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.614 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_002458.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MUC5B
NM_002458.3
MANE Select
c.7676C>Tp.Thr2559Met
missense
Exon 31 of 49NP_002449.2
MUC5B-AS1
NR_157183.1
n.57-1918G>A
intron
N/A

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MUC5B
ENST00000529681.5
TSL:5 MANE Select
c.7676C>Tp.Thr2559Met
missense
Exon 31 of 49ENSP00000436812.1
MUC5B-AS1
ENST00000532061.2
TSL:5
n.57-1918G>A
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.417
AC:
61068
AN:
146584
Hom.:
12938
Cov.:
25
show subpopulations
Gnomad AFR
AF:
0.313
Gnomad AMI
AF:
0.518
Gnomad AMR
AF:
0.521
Gnomad ASJ
AF:
0.427
Gnomad EAS
AF:
0.633
Gnomad SAS
AF:
0.415
Gnomad FIN
AF:
0.502
Gnomad MID
AF:
0.383
Gnomad NFE
AF:
0.426
Gnomad OTH
AF:
0.425
GnomAD2 exomes
AF:
0.446
AC:
106515
AN:
238782
AF XY:
0.441
show subpopulations
Gnomad AFR exome
AF:
0.299
Gnomad AMR exome
AF:
0.563
Gnomad ASJ exome
AF:
0.408
Gnomad EAS exome
AF:
0.630
Gnomad FIN exome
AF:
0.444
Gnomad NFE exome
AF:
0.415
Gnomad OTH exome
AF:
0.443
GnomAD4 exome
AF:
0.382
AC:
555675
AN:
1454898
Hom.:
56234
Cov.:
107
AF XY:
0.383
AC XY:
276877
AN XY:
723846
show subpopulations
African (AFR)
AF:
0.285
AC:
9516
AN:
33370
American (AMR)
AF:
0.502
AC:
22147
AN:
44134
Ashkenazi Jewish (ASJ)
AF:
0.385
AC:
10015
AN:
26002
East Asian (EAS)
AF:
0.659
AC:
26051
AN:
39522
South Asian (SAS)
AF:
0.386
AC:
33128
AN:
85918
European-Finnish (FIN)
AF:
0.459
AC:
24258
AN:
52802
Middle Eastern (MID)
AF:
0.371
AC:
2109
AN:
5682
European-Non Finnish (NFE)
AF:
0.366
AC:
404947
AN:
1107352
Other (OTH)
AF:
0.391
AC:
23504
AN:
60116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.534
Heterozygous variant carriers
0
24907
49813
74720
99626
124533
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
14660
29320
43980
58640
73300
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.417
AC:
61108
AN:
146694
Hom.:
12953
Cov.:
25
AF XY:
0.423
AC XY:
30222
AN XY:
71366
show subpopulations
African (AFR)
AF:
0.313
AC:
12580
AN:
40230
American (AMR)
AF:
0.521
AC:
7657
AN:
14700
Ashkenazi Jewish (ASJ)
AF:
0.427
AC:
1440
AN:
3374
East Asian (EAS)
AF:
0.633
AC:
2992
AN:
4726
South Asian (SAS)
AF:
0.415
AC:
1884
AN:
4544
European-Finnish (FIN)
AF:
0.502
AC:
5026
AN:
10014
Middle Eastern (MID)
AF:
0.367
AC:
105
AN:
286
European-Non Finnish (NFE)
AF:
0.426
AC:
28102
AN:
65928
Other (OTH)
AF:
0.431
AC:
868
AN:
2016
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
1566
3132
4698
6264
7830
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
560
1120
1680
2240
2800
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.333
Hom.:
1293
ExAC
AF:
0.430
AC:
51773

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Jun 09, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

not specified Benign:1
Mar 28, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Gene associated with pulmonary fibrosis

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.085
BayesDel_addAF
Benign
-0.72
T
BayesDel_noAF
Benign
-0.66
CADD
Benign
1.2
DANN
Benign
0.50
DEOGEN2
Benign
0.023
T
Eigen
Benign
-0.92
Eigen_PC
Benign
-1.1
FATHMM_MKL
Benign
0.036
N
LIST_S2
Benign
0.37
T
MetaRNN
Benign
0.000029
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
1.9
L
PhyloP100
-3.9
PrimateAI
Benign
0.18
T
PROVEAN
Benign
-1.3
N
REVEL
Benign
0.085
Sift
Uncertain
0.0040
D
Vest4
0.015
ClinPred
0.010
T
GERP RS
-3.8
Varity_R
0.017
gMVP
0.21
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs60787297; hg19: chr11-1265786; COSMIC: COSV71589896; API